General (Tables)

9 Months Ended

Sep. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

Derivative instruments measured at fair value and their classification in the condensed consolidated balance sheets are presented in the following table (in thousands):

 

	Assets (liabilities) as of September 30, 2026 (unaudited)				Assets (liabilities) as of December 31, 2025
	Notional Amount		Fair Value		Notional Amount		Fair Value
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in prepaid expenses and other short-term assets	$	126,558	$	14,881	$	187,767	$	21,605
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in accrued expenses and other short-term liabilities	$	53,228	$	(1,029)	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in long-term other assets	$	29,791	$	775	$	123,959	$	6,465
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in long-term other liabilities	$	40,729	$	(711)	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in prepaid expenses and other short-term assets	$	116,422	$	2,267	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in accrued expenses and other short-term liabilities	$	13,006	$	(78)	$	128,132	$	(2,515)
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in long-term other assets	$	96,449	$	1,922	$	—	$	—
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in long-term other liabilities	$	12,081	$	(14)	$	185,688	$	(1,691)

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income

Net gains (losses) related to cash flow hedges that were reclassified from accumulated other comprehensive income to the condensed consolidated statements of operations are presented in the following table (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2026		2025		2026		2025
	(unaudited)
Revenues	$	(1,246)	$	143	$	(2,714)	$	1,027
Cost of revenues	(6)		182		111		71
Research and development	5,861		1,378		16,983		(227)
Sales and marketing	12		348		240		39
General and administrative	1,722		380		5,024		(47)
Financial income, net	—		94		201		(337)
Total net gain related to cash flow hedges	$	6,343	$	2,525	$	19,845	$	526

Schedule of Cash, Cash Equivalents and Investments

Cash equivalents and marketable securities consist of the following (in thousands):

 

	As of September 30, 2026
	(unaudited)
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Cash equivalents
Money market funds	$	170,763	$	—	$	—	$	170,763
Total	$	170,763	$	—	$	—	$	170,763
Marketable securities
US Treasury securities	$	323,746	$	7	$	(1,040)	$	322,713
Total	$	323,746	$	7	$	(1,040)	$	322,713
Long-term marketable securities
US Treasury securities	$	309,450	$	—	$	(3,108)	$	306,342
Total	$	309,450	$	—	$	(3,108)	$	306,342

	As of December 31, 2025
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Cash equivalents
Money market funds	$	120,155	$	—	$	—	$	120,155
Total	$	120,155	$	—	$	—	$	120,155
Marketable securities
US Treasury securities	$	679,959	$	1,267	$	(1)	$	681,225
Total	$	679,959	$	1,267	$	(1)	$	681,225
Long-term marketable securities
US Treasury securities	$	186,971	$	231	$	—	$	187,202
Total	$	186,971	$	231	$	—	$	187,202